drugset / Trial / NCT02467647

The Effects of Huang-Lian-Jie-Du-Tang(HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy

NCT02467647

Phase 1 Unknown 500 enrolled Wuhan University Tongji Hospital · collab
RandomizedCrossoverSingle-blindTreatment

Summary

To investigate the efficacy of the combination of Thalidomide and Huang-Lian-Jie-Du-Tang on the patients with multiple myeloma in maintain therapy.

Timeline

Start
2015-01
Primary completion
2018-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Huang-Lian-Jie-Du-Tang Unknown 150 ml
Subject Thalidomide Other / unclassified 100 mg Oral

Indications